Ozempic for Weight Loss in Kenya

Prescription semaglutide support for eligible patients seeking medically supervised weight management in Kenya.

Eligibility Screening Once Weekly Injection Medical Follow-Up

Ozempic in Kenya: Semaglutide Weight Management Support

Ozempic is a prescription semaglutide injection originally used in type 2 diabetes care and sometimes considered by clinicians as part of a medically supervised weight management plan. At Rayhaan Healthcare, patients are assessed before treatment so the team can confirm whether medication is appropriate, safe, and aligned with their health goals.

A safe programme should include medical history review, BMI assessment, screening for contraindications, discussion of possible side effects, nutrition support, and follow-up. Patients also need guidance on injection use, dose changes, storage, missed doses, and when to contact the clinical team.

  • Weight management pathways are clinically led and connected to wider diagnostic, lab, and surgical services where needed.
  • Baseline checks may be recommended before or during treatment depending on your health profile.
  • Consultations are available at Rayhaan Healthcare in Parklands, Nairobi.
10-15%Study-reported weight loss in selected eligible adults
OnceWeekly subcutaneous injection
GLP-1Hormone mimetic mechanism

GLP-1 Receptor Agonist

Ozempic (Semaglutide) mimics the GLP-1 gut hormone released after eating. It signals your brain to reduce appetite, slows gastric emptying so you feel full longer, and regulates blood sugar - all from a once-weekly injection.

  • Suppresses appetite and reduces calorie intake
  • Slows stomach emptying for prolonged fullness
  • Lowers blood sugar and HbA1C
  • Reduces systemic inflammation
  • May support cardiometabolic risk management when prescribed appropriately
  • Supports blood sugar monitoring as part of a medical plan
Ozempic weight loss Kenya

Eligibility & Contraindications

Suitable For

  • BMI >= 27 with at least one comorbidity
  • BMI >= 30 regardless of other conditions
  • Adults with type 2 diabetes seeking weight and glucose control
  • Patients wanting a clinically validated non-surgical option

Contraindications

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia type 2 (MEN 2)
  • Known semaglutide allergy
  • Pregnancy or breastfeeding
Safe Use

What Happens Before an Ozempic Programme?

Clinical Review

The team reviews your weight history, symptoms, medical conditions, medicines, previous attempts, and goals before recommending a pathway.

BMI and Risk Assessment

Your BMI, waist measurements, blood pressure, diabetes risk, and metabolic health may guide whether medication or another plan is more suitable.

Lab Support When Needed

Selected patients may need blood sugar, kidney, liver, cholesterol, thyroid, or other tests before or during treatment.

Lifestyle Plan

Medication works best with nutrition structure, hydration, movement, sleep support, and habits that can continue after treatment.

Side-Effect Monitoring

Nausea, vomiting, diarrhoea, constipation, reflux, or low appetite should be monitored, especially during dose changes.

Follow-Up

Regular review helps assess tolerance, results, safety, and whether the treatment plan should continue or change.

Start Your Ozempic Programme

Book a medical consultation - our team will assess your eligibility and design your programme.

We welcome all major insurance providers — AAR, Jubilee, CIC, UAP, Resolution, Britam, MUA, AON Minet & more. Verify your cover →

WhatsApp